Cargando…
Defining the optimal bilirubin level before hepatectomy for hilar cholangiocarcinoma
BACKGROUND: In the management of operable hilar cholangiocarcinoma (HC) patients with hyperbilirubinemia, preoperative biliary drainage is a measure to bring down the bilirubin to a certain level so as to avoid adverse postoperative outcomes that would otherwise result from hyperbilirubinemia. A cut...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7513475/ https://www.ncbi.nlm.nih.gov/pubmed/32967634 http://dx.doi.org/10.1186/s12885-020-07385-0 |
_version_ | 1783586392202280960 |
---|---|
author | She, Wong Hoi Cheung, Tan To Ma, Ka Wing Tsang, Simon H. Y. Dai, Wing Chiu Chan, Albert C. Y. Lo, Chung Mau |
author_facet | She, Wong Hoi Cheung, Tan To Ma, Ka Wing Tsang, Simon H. Y. Dai, Wing Chiu Chan, Albert C. Y. Lo, Chung Mau |
author_sort | She, Wong Hoi |
collection | PubMed |
description | BACKGROUND: In the management of operable hilar cholangiocarcinoma (HC) patients with hyperbilirubinemia, preoperative biliary drainage is a measure to bring down the bilirubin to a certain level so as to avoid adverse postoperative outcomes that would otherwise result from hyperbilirubinemia. A cutoff value of bilirubin level in this context is needed but has not been agreed upon without controversy. This retrospective study aimed to identify a cutoff of preoperative bilirubin level that would minimize postoperative morbidity and mortality. METHODS: Data of patients having hepatectomy with curative intent for HC were analyzed. Discriminative analysis was performed to identify the preoperative bilirubin level that would make a survival difference. The identified level was used as the cutoff to divide patients into two groups. The groups were compared. RESULTS: Ninety patients received hepatectomy with curative intent for HC. Their median preoperative bilirubin level was 23 μmol/L. A cutoff preoperative bilirubin level of 75 μmol/L was derived from Youden’s index (sensitivity 0.333; specificity 0.949) and confirmed to be optimal by logistic regression (relative risk 9.250; 95% confidence interval 1.932–44.291; p = 0.005), with mortality shown to be statistically different at 90 days (p = 0.008). Patients were divided into Group A (≤75 μmol/L; n = 82) and Group B (> 75 μmol/L; n = 8). Group B had a higher preoperative bilirubin level (p < 0.001), more intraoperative blood loss (3.12 vs 1.4 L; p = 0.008), transfusion (100% vs 42.0%; p = 0.011) and replacement (2.45 vs 0.0 L; p < 0.001), more postoperative renal complications (p = 0.036), more in-hospital deaths (50% vs 8.5%; p = 0.004), and more 90-day deaths (50% vs 9.8%; p = 0.008). Group A had a longer follow-up period (p = 0.008). The groups were otherwise comparable. Disease-free survival was similar between groups (p = 0.142) but overall survival was better in Group A (5-year, 25.2% vs 0%; p < 0.001). On multivariate analysis, preoperative bilirubin level and intraoperative blood replacement were risk factors for 90-day mortality. CONCLUSION: A cutoff value of preoperative bilirubin level of 75 μmol/L is suggested, as the study showed that a preoperative bilirubin level ≤ 75 μmol/L resulted in significantly less blood replacement necessitated by blood loss during operation and significantly better patient survival after surgery. |
format | Online Article Text |
id | pubmed-7513475 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-75134752020-09-25 Defining the optimal bilirubin level before hepatectomy for hilar cholangiocarcinoma She, Wong Hoi Cheung, Tan To Ma, Ka Wing Tsang, Simon H. Y. Dai, Wing Chiu Chan, Albert C. Y. Lo, Chung Mau BMC Cancer Research Article BACKGROUND: In the management of operable hilar cholangiocarcinoma (HC) patients with hyperbilirubinemia, preoperative biliary drainage is a measure to bring down the bilirubin to a certain level so as to avoid adverse postoperative outcomes that would otherwise result from hyperbilirubinemia. A cutoff value of bilirubin level in this context is needed but has not been agreed upon without controversy. This retrospective study aimed to identify a cutoff of preoperative bilirubin level that would minimize postoperative morbidity and mortality. METHODS: Data of patients having hepatectomy with curative intent for HC were analyzed. Discriminative analysis was performed to identify the preoperative bilirubin level that would make a survival difference. The identified level was used as the cutoff to divide patients into two groups. The groups were compared. RESULTS: Ninety patients received hepatectomy with curative intent for HC. Their median preoperative bilirubin level was 23 μmol/L. A cutoff preoperative bilirubin level of 75 μmol/L was derived from Youden’s index (sensitivity 0.333; specificity 0.949) and confirmed to be optimal by logistic regression (relative risk 9.250; 95% confidence interval 1.932–44.291; p = 0.005), with mortality shown to be statistically different at 90 days (p = 0.008). Patients were divided into Group A (≤75 μmol/L; n = 82) and Group B (> 75 μmol/L; n = 8). Group B had a higher preoperative bilirubin level (p < 0.001), more intraoperative blood loss (3.12 vs 1.4 L; p = 0.008), transfusion (100% vs 42.0%; p = 0.011) and replacement (2.45 vs 0.0 L; p < 0.001), more postoperative renal complications (p = 0.036), more in-hospital deaths (50% vs 8.5%; p = 0.004), and more 90-day deaths (50% vs 9.8%; p = 0.008). Group A had a longer follow-up period (p = 0.008). The groups were otherwise comparable. Disease-free survival was similar between groups (p = 0.142) but overall survival was better in Group A (5-year, 25.2% vs 0%; p < 0.001). On multivariate analysis, preoperative bilirubin level and intraoperative blood replacement were risk factors for 90-day mortality. CONCLUSION: A cutoff value of preoperative bilirubin level of 75 μmol/L is suggested, as the study showed that a preoperative bilirubin level ≤ 75 μmol/L resulted in significantly less blood replacement necessitated by blood loss during operation and significantly better patient survival after surgery. BioMed Central 2020-09-23 /pmc/articles/PMC7513475/ /pubmed/32967634 http://dx.doi.org/10.1186/s12885-020-07385-0 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article She, Wong Hoi Cheung, Tan To Ma, Ka Wing Tsang, Simon H. Y. Dai, Wing Chiu Chan, Albert C. Y. Lo, Chung Mau Defining the optimal bilirubin level before hepatectomy for hilar cholangiocarcinoma |
title | Defining the optimal bilirubin level before hepatectomy for hilar cholangiocarcinoma |
title_full | Defining the optimal bilirubin level before hepatectomy for hilar cholangiocarcinoma |
title_fullStr | Defining the optimal bilirubin level before hepatectomy for hilar cholangiocarcinoma |
title_full_unstemmed | Defining the optimal bilirubin level before hepatectomy for hilar cholangiocarcinoma |
title_short | Defining the optimal bilirubin level before hepatectomy for hilar cholangiocarcinoma |
title_sort | defining the optimal bilirubin level before hepatectomy for hilar cholangiocarcinoma |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7513475/ https://www.ncbi.nlm.nih.gov/pubmed/32967634 http://dx.doi.org/10.1186/s12885-020-07385-0 |
work_keys_str_mv | AT shewonghoi definingtheoptimalbilirubinlevelbeforehepatectomyforhilarcholangiocarcinoma AT cheungtanto definingtheoptimalbilirubinlevelbeforehepatectomyforhilarcholangiocarcinoma AT makawing definingtheoptimalbilirubinlevelbeforehepatectomyforhilarcholangiocarcinoma AT tsangsimonhy definingtheoptimalbilirubinlevelbeforehepatectomyforhilarcholangiocarcinoma AT daiwingchiu definingtheoptimalbilirubinlevelbeforehepatectomyforhilarcholangiocarcinoma AT chanalbertcy definingtheoptimalbilirubinlevelbeforehepatectomyforhilarcholangiocarcinoma AT lochungmau definingtheoptimalbilirubinlevelbeforehepatectomyforhilarcholangiocarcinoma |